Vaxelis is the first hexavalent combination vaccine indicated for active immunization to prevent diphtheria, tetanus, pertussis, poliomyelitis, hepatitis B, and invasive disease due to Haemophilus influenzae type b.
The report included 10262 SARS-CoV-2 vaccine breakthrough infections in 46 US states and territories among 101 million fully vaccinated individuals as of April 30, 2021.
The TeenCOVE study (ClinicalTrials.gov: NCT04649151) included over 3700 US adolescents aged 12 to less than 18 years.
The FDA has authorized undiluted, thawed vials of the Pfizer-BioNTech COVID-19 Vaccine to be stored in the refrigerator at 2°C to 8°C (35°F to 46°F) for up to 1 month.
Positive topline results were announced from two phase 3 studies evaluating V114, an investigational 15-valent pneumococcal conjugate vaccine, in pediatric patients for the prevention of invasive pneumococcal disease.
Fully vaccinated individuals may resume indoor and outdoor activities without wearing masks or physical distancing, except under certain circumstances.
The recommendation follows the Food and Drug Administration’s authorization for this patient population earlier this week.
With many Americans awaiting to be vaccinated, while others indicating they are unlikely to get the jab, we spoke with 2 experts for their perspectives regarding this controversial topic.
Violations included not properly disinfecting equipment, not following procedures meant to prevent contamination, improperly trained employees.
Oncologists and patients should be aware of the potential manifestations of the COVID-19 vaccination on imaging and the consequences this might have on disease assessment, treatment monitoring, and decision-making.
